After the Serum Institute of India reduced the price of “Covisheild” vaccine for the states yesterday, Bharat Biotech on Thursday lowered the price of Covaxin to Rs. 400 per dose for state government.
Bharat Biotech expressed deep concern with the critical pandemic circumstances that India is facing at this time. Recognizing the enormous challenges to the public health care system, the company has made Covaxin available to State Governments at a price of Rs. 400 per dose.
“We wish to be transparent in our approach to pricing which was determined by internally funded product development, several operationally-intensive BSL-3 manufacturing facilities (the first of its kind in our country), and clinical trials,” the company said.
“We wish to champion “Innovation in India” and our commitment to public health is absolute! For the last year, Team Bharat Biotech has been fearlessly handling Live SARS-CoV-2 virus strains, tirelessly working round-the-clock while overcoming many challenges given the uncertainty of the pandemic. With the greater part of the organization’s facilities and resources being diverted to COVID-19 vaccines, we continue to work towards offering superior COVID-1 9 vaccines and sincerely wish that this gesture enables our country towards a faster recovery.
We offer our prayers to all the citizens of India and wish them safety and health!,” the press statement by Bharat Biotech further added.
Bharat Biotech – COVAXIN® Announcement – April 29, 2021 pic.twitter.com/RgnROIfUCe
— BharatBiotech (@BharatBiotech) April 29, 2021
